Blood Pressure Medications Don’t Increase Risk for Severe COVID-According to New Wuhan Data Analysis

Potential good news for those with high blood pressure… taking antihypertensive medication, including ACE-inhibitors and ARBs, does not seem to increase the risk of more severe COVID-19 infection. This is based on a collective meta-analysis of group data from Wuhan, China reported in the European Heart Journal. This had previously been a potential concern since…

Scientific Papers Retracted from One of the World’s Most Prestigious Journals

Last week, the prestigious medical journal, The Lancet, retracted two COVID-19-related papers. One of those papers had reported on negative effects of hydroxycloroquine as a potential treatment option, leading to much controversy over the use of the drug. The reason for the retraction? Surgisphere Corporation, the company providing the underlying database of information that was…

Detecting Nutritional Deficiencies in Sweat – A New Possibility

Biosensors that provide realtime feedback on health-related parameters are considered profoundly useful tools for optimizing health status and encouraging adherence to healthier activities. A new wearable device now does this for vitamin C. The device contains the enzyme ascorbate oxidase, which on contact with vitamin C (ascorbic acid) changes the electrochemical current flow. Given the…

Inflammation resolution is a key strategy for escalating COVID-19 symptoms – a new paper and free DrKF webinar replay

From the folks that brought us Specialized Pro-resolving Lipid Mediators (SPMs), comes a new peer-reviewed paper that highlights the potential for SPMs in addressing pro-inflammatory cytokine production and cytokine storm in COVID-19. SPMs stimulate macrophage-mediated clearance of cellular debris and reduce pro-inflammatory cytokine levels. They also promote anti-viral B cell antibodies and other white blood…

Organs targeted by ACE-2-utilizing viruses like COVID-19

This infographic from Scientist illustrating the many organs that the virus can gain entry to using ACE2 or TMRPSS2 receptors (definitive evidence for viral presence in the various organs is still being established, but the presence of the receptors provides a road map for investigation). Certainly this influences the wide variety of COVID presentations we…

Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

ABSTRACT Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory cytokines and chemokines, including interleukin-1 (IL-1), IL-6, CCL2 protein, and CXCL10 protein. In…

The Functional Medicine Approach to COVID-19: Additional Research on Nutraceuticals and Botanicals

In this paper, the Institute for Functional Medicine (IFM) added to the list of nutraceuticals and botanicals introduced earlier in their first article, The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents. Periodically, IFM will update the original list to highlight other agents that may be considered as complementary treatments against COVID-19. Along…